Manufacturing, Expression Systems

Jun 01, 2018
BioPharm International
Transcriptomics plays a role in influencing the production of recombinant therapeutics in microbial and mammalian hosts.
Nov 13, 2017
By BioPharm International Editors
The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.
Nov 01, 2017
BioPharm International
Platform technologies facilitate
development and accelerate commercialization of protein therapeutics.
Oct 12, 2017
By BioPharm International Editors
The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.
Dec 01, 2016
BioPharm International
The baculovirus-insect cell system can produce large quantities of complex protein in a short period of time.
Sep 01, 2016
By BioPharm International Editors
The platform combines an expression system with equipment and process controls to enable rapid development and scale-up of robust titers.
May 01, 2015
BioPharm International
Choosing the optimal protein expression vector depends on strain, promoter, and a number of other factors.
Dec 08, 2014
By BioPharm International Editors
Under an NIH contract, Paragon Bioservices will design a manufacturing process for recombinant human rhE-selectin protein.
May 01, 2014
BioPharm International
New human and plant-based expressions systems can enable faster product development and improve quality at potentially lower costs.
May 01, 2012
BioPharm International
The author highlights novel strains and methods that have recently been shown to express multidisulfide bonded proteins.
lorem ipsum